Jun 20 |
Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients
|
May 29 |
PTC Therapeutics to Participate at Upcoming Investor Conference
|
May 28 |
PTC Therapeutics announces validation of Sepiapterin European MAA
|
May 28 |
PTC Therapeutics Announces Validation of Sepiapterin European MAA
|
May 25 |
Insider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC Therapeutics Inc (PTCT)
|
May 24 |
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
|
May 23 |
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
|
May 22 |
PTC Therapeutics: Riding The Regulatory Rollercoaster With Translarna
|
May 22 |
News Flash: Analysts Just Made A Notable Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Forecasts
|
May 21 |
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
|